Viewing Study NCT06397703


Ignite Creation Date: 2025-12-24 @ 7:13 PM
Ignite Modification Date: 2026-02-25 @ 11:49 PM
Study NCT ID: NCT06397703
Status: RECRUITING
Last Update Posted: 2025-03-26
First Post: 2024-04-29
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer
Sponsor: NYU Langone Health
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module